Plasma Levels of Cyclic GMP, Immune Parameters and Depressive Status during Interferon Therapy
作者:
Ariyuki Kagaya,
Yosuke Uchitomi,
Eiichi Takezaki,
Mayumi Fukue,
Ken Tsukano,
Akira Kugaya,
Hideaki Minagawa,
Minoru Takebayashi,
Hidenobu Zensho,
Takahiro Oyamada,
Shigeto Yamawaki,
期刊:
Neuropsychobiology
(Karger Available online 1997)
卷期:
Volume 35,
issue 3
页码: 128-131
ISSN:0302-282X
年代: 1997
DOI:10.1159/000119333
出版商: S. Karger AG
关键词: Interferon;Cyclic GMP;Soluble interleukin-2 receptor;Depression
数据来源: Karger
摘要:
In this report, we investigated the relationship between depressive symptoms and plasma interferon (IFN)-α-like immunoreactivity, cyclic GMP (cGMP) and soluble interleukin-2 receptor (sIL-2R) levels during IFN therapy. An altered mood state was observed in 5 of 26 patients. IFN-α-like immunoreactivity in the depressed group tended to be elevated. cGMP levels of depressed patients were significantly greater than those of control subjects before and 6 weeks after IFN therapy. However, sIL-2R levels were not different between the two groups. These results suggest that a number of patients suffered from depression during IFN therapy and that patients had greater concentrations of cGMP level
点击下载:
PDF
(791KB)
返 回